Trial intelligence / Profile preview

Blade Runner Trial

2011-000790-31Phase 4Active

Sponsor
Azienda Ospedaliero-Universitaria Policlinico Umberto I
Start
Mar 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of propofol and sevoflurane in cervical myelopathy (2 arms), sponsored by Azienda Ospedaliero-Universitaria Policlinico Umberto I. Primary endpoints: Mean arterial pressure during induction and intubation and Respiratory drive and ventilatory effects. Started Mar 2012; status: active.

02

Drugs

propofolsevoflurane
03

Conditions

cervical myelopathy

Beyond the preview

Go deeper on 2011-000790-31.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2011-000790-31.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call